• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated heal

tetano

Editor, Senior Moderator
Sci Rep


. 2023 May 24;13(1):8416.
doi: 10.1038/s41598-023-35471-3. Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers

Pekka Kolehmainen[SUP] 1 [/SUP], Moona Huttunen[SUP] 2 [/SUP], Alina Iakubovskaia[SUP] 3 [/SUP], Sari Maljanen[SUP] 2 [/SUP], Sisko Tauriainen[SUP] 2 [/SUP], Emrah Yatkin[SUP] 4 [/SUP], Arja Pasternack[SUP] 3 [/SUP], Rauno Naves[SUP] 3 [/SUP], Laura Toivonen[SUP] 5 [/SUP], Paula A Tähtinen[SUP] 5 [/SUP], Lauri Ivaska[SUP] 5 6 [/SUP], Johanna Lempainen[SUP] 2 5 7 [/SUP], Ville Peltola[SUP] 5 6 [/SUP], Matti Waris[SUP] 2 7 [/SUP], Laura Kakkola[SUP] #[/SUP][SUP] 2 [/SUP], Olli Ritvos[SUP] #[/SUP][SUP] 3 [/SUP], Ilkka Julkunen[SUP] #[/SUP][SUP] 2 6 7 [/SUP]



Affiliations
Abstract

The prevalence of seasonal human coronavirus (HCoV) infections in early childhood and adults has not been well analyzed in longitudinal serological studies. Here we analyzed the changes in HCoV (229E, HKU1, NL63, OC43, MERS, and SARS-CoV-2) spike-specific antibody levels in follow-up serum specimens of 140 children at the age of 1, 2, and 3 years, and of 113 healthcare workers vaccinated for Covid-19 with BNT162b2-vaccine. IgG antibody levels against six recombinant HCoV spike subunit 1 (S1) proteins were measured by enzyme immunoassay. We show that by the age of three years the cumulative seropositivity for seasonal HCoVs increased to 38-81% depending on virus type. BNT162b2 vaccinations increased anti-SARS-CoV-2 S1 antibodies, but no increase in seasonal coronavirus antibodies associated with vaccinations. In healthcare workers (HCWs), during a 1-year follow-up, diagnostic antibody rises were seen in 5, 4 and 14% of the cases against 229E, NL63 and OC43 viruses, respectively, correlating well with the circulating HCoVs. In 6% of the HCWs, a diagnostic antibody rise was seen against S1 of HKU1, however, these rises coincided with anti-OC43 S1 antibody rises. Rabbit and guinea pig immune sera against HCoV S1 proteins indicated immunological cross-reactivity within alpha-CoV (229E and NL63) and beta-CoV (HKU1 and OC43) genera.


 
Back
Top Bottom